Insider filing
Traded Apr 24 · filed 3 days later
Routine share withholding; mechanical by default.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
MBIO · NASDAQ · Pharmaceutical Preparations
$0.3947−0.0267 (−6.34%)
Close of Nov 16, 2026, vs Nov 13 · end-of-day, not a live quote
Mustang Bio (MBIO) · oqro.io/stocks/MBIO · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Including 2 routine filings (option exercises, tax withholding, grants, gifts). Open-market trades only
Insider filing
Traded Apr 24 · filed 3 days later
Routine share withholding; mechanical by default.
Insider filing
Traded Jan 2 · filed 3 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider buying
First insider buy since Sep 2022Traded Dec 30, 2025 · filed the same day
Since the trade −58.5% · S&P 500 +7.7% · to Nov 16
A Mustang Bio director paid $238 out of pocket for Mustang Bio shares. Shares held went up 633% with this purchase.
Insider selling
Traded Dec 30, 2025 · filed the same dayNot reported under a pre-arranged trading plan
Since the trade −58.5% · S&P 500 +7.7% · to Nov 16
A Mustang Bio director sold $238 of Mustang Bio shares. The filing does not indicate a pre-arranged trading plan.
Insider selling
Traded Dec 30, 2025 · filed the same dayNot reported under a pre-arranged trading plan
Since the trade −58.5% · S&P 500 +7.7% · to Nov 16
A Mustang Bio director sold $4 of Mustang Bio shares. The filing does not indicate a pre-arranged trading plan.
1 open-market purchase and 2 open-market sales by insiders of MBIO between Jul 15, 2023 and today, placed against the company's last 4 earnings releases. The latest on file was filed Apr 29, 2024. The data provider lists the next release for Mar 17, 2027; that date may change.
PurchaseSale30 days before a release30 days after
| Earnings release | 30 days before | On the day | 30 days after |
|---|---|---|---|
| Apr 29, 2024 | None | None | None |
| Mar 11, 2024 | None | None | None |
| Nov 14, 2023 | None | None | None |
| Aug 14, 2023 | None | None | None |
Companies set trading windows, which usually close shortly before results and reopen after them, and insiders may trade under 10b5-1 plans adopted months earlier. A date alone does not show what a person knew or why they traded. Past release dates are the dates the company filed its 8-K with Item 2.02. An upcoming date, when one is mentioned, comes from the data provider's earnings calendar (Finnhub): it is not a company filing, it is not estimated by OQRO, and it may change. Open-market purchases and sales as reported on Form 4. Largest purchases around earnings, all companies